- Company’s first greenfield investment since 2007
- New, highly automated site to be located in Grecia, producing components for knee and hip implants
Alajuela, September 25, 2025. Zimmer Biomet Holdings, Inc.,a global medical technology leader, has chosen Costa Rica for the construction of its new manufacturing plant in Grecia, Alajuela. This marks the company’s first greenfield investment in nearly 20 years, reflecting its strategic commitment to long-term global growth, operational excellence, and supply chain resilience.
Through this investment, the company expects to generate up to 500 direct jobs by 2033. The new positions will range from machinists, manufacturing operators, engineers, and material handlers to leadership roles in operations, engineering, human resources, quality, and facilities.
“This investment will increase the geographic diversity and resiliency of our global supply chain to serve our customers and their patients, while fulfilling our mission to alleviate pain and improve quality of life for people around the world,” said Ken Tripp, Senior Vice President of Global Operations and Logistics at Zimmer Biomet.
The state-of-the-art, highly automated 22,000 m² facility will specialize in high-volume, cost-efficient manufacturing of key products, including components for orthopedic knee and hip implants.
Manuel Tovar, Minister of Foreign Trade, stated: “The announcement of the construction of Zimmer Biomet Holdings, Inc.’s new manufacturing plant in Grecia is excellent news for Costa Rica. Zimmer Biomet, a global leader in medical technology, reaffirms with this project the country’s competitive advantages in attracting investment and creating high-quality jobs. Our country offers a unique combination of highly skilled talent, stability, and a business environment that fosters innovation — enabling companies to optimize operations, encourage investment, and generate quality employment”.
Laura López, CEO of the Trade and Investment Promotion Agency of Costa Rica (PROCOMER), stated: “The arrival of a company like Zimmer Biomet with its first greenfield project in nearly two decades demonstrates the strength of our country’s value proposition. Costa Rica has consolidated itself as a strategic hub for medical device companies, a sector that represents 48% of our goods exports and already brings together more than 95 companies established in the country. This investment, as it involves a new original equipment manufacturer, confirms that we are moving firmly toward a high-value productive model, aligned with our priority of fostering balanced growth beyond the Greater Metropolitan Area and with our long-standing commitment to sustainability and innovation”.
To be located outside of the Great Metropolitan Area in Costa Rica’s Green Valley (far from the country’s main cities), the site will reflect Zimmer Biomet’s strong commitment to sustainability. Designed to minimize environmental impact, the facility will incorporate solar panels, water reuse systems, and a Zero Waste to Landfill approach.
“The decision by Zimmer Biomet to expand its operations into Costa Rica Green Valley reflects the international community’s confidence in our country as an investment destination. This step reaffirms Portafolio Inmobiliario’s commitment to creating a world-class ecosystem that fosters innovation, sustainability, and an optimal environment for global companies to consolidate their operations in Costa Rica,” said Alfredo Volio, Executive Director of Portafolio Inmobiliario.
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. The company transforms the patient’s experience through innovative products and a suite of integrated digital and robotic technologies that leverage data, analytics, and artificial intelligence.
